These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4010375)

  • 1. [Duration of the immunoprophylaxis produced by hepatitis B vaccine].
    Hernández JM; Piqueras J; Esteban JI; Esteban R
    Med Clin (Barc); 1985 May; 84(17):714-5. PubMed ID: 4010375
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccine.
    Drug Ther Bull; 1985 Jul; 23(13):49-51. PubMed ID: 3160568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inoculation against hepatitis B. Vaccines, mechanism of action, duration of the inoculation protection and revaccination].
    Jilg W
    Dtsch Med Wochenschr; 1989 Apr; 114(15):596-8. PubMed ID: 2649350
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serologic epidemiology of hepatitis B viral infection and observation on the immunologic effect of hepatitis B vaccine].
    Ge QY
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Mar; 22(2):92-4. PubMed ID: 3215090
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccines against the hepatitis B virus. The outstanding problems].
    Carreño V; Quiroga JA
    Rev Clin Esp; 1990 Oct; 187(5):247-8. PubMed ID: 2102538
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of perinatal transmission of hepatitis B virus infection by HB-Ig and HB-vaccine].
    Ohryohji F; Umezu T; Ootsuka M; Kanda S
    Fukuoka Igaku Zasshi; 1984 Oct; 75(10):594-7. PubMed ID: 6240438
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serologic indicators of the preventive activity of gamma globulin produced by the Warsaw Laboratory of Sera and Vaccines in 1972-1984 against viral hepatitis].
    Karwowska S; Kacperska E; Seyfried H; Nowosławski A
    Przegl Epidemiol; 1986; 40(2):193-9. PubMed ID: 2433711
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis B protective inoculation. The problem of inadequate anti-HB production].
    Dennhöfer L
    Dtsch Med Wochenschr; 1990 Oct; 115(41):1560-5. PubMed ID: 2209446
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to hepatitis B vaccine in medical & paramedical personnel in India.
    Sehgal A; Pavri K; Arankalle V; Jhala CI; Dhorje SP; Ramamoorthy CL
    Indian J Med Res; 1987 Mar; 85():231-4. PubMed ID: 2956189
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of hepatitis B vaccine in neonates: induction of an anti-HBs immune response and interruption of maternal HBsAg transmission].
    Wang YJ
    Zhonghua Yi Xue Za Zhi; 1984 Dec; 64(12):741-4, 792. PubMed ID: 6242233
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune response to hepatitis B vaccine in the staff of a hemodialysis unit.
    Landa L; Rattoni N; Lehne C; Trujillo J; Landa E
    Arch Invest Med (Mex); 1984; 15(2):133-8. PubMed ID: 6487003
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response to half dose hepatitis B vaccine.
    Chan SH; Tobias MI
    N Z Med J; 1987 Sep; 100(831):570. PubMed ID: 2967451
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoprophylaxis of viral hepatitis].
    Biesiada G; Mach T
    Przegl Lek; 2003; 60(9):598-601. PubMed ID: 15065341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of serum markers of hepatitis B virus in medical and non-medical personnel in a general hospital].
    Sánchez-Quijano A; Rivera F; Lissen E; Ollero M; Lozano F; García de Pesquera F; Vázquez R; Andreu-Kern F
    Med Clin (Barc); 1984 Jun; 83(1):1-3. PubMed ID: 6482541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vaccines against hepatitis B].
    Viazov SO
    Vopr Virusol; 1984; 29(6):656-63. PubMed ID: 6396952
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired immunogenicity of hepatitis B vaccine in obese persons.
    Weber DJ; Rutala WA; Samsa GP; Bradshaw SE; Lemon SM
    N Engl J Med; 1986 May; 314(21):1393. PubMed ID: 2939347
    [No Abstract]   [Full Text] [Related]  

  • 18. Suboptimal response to hepatitis B vaccine in Nova Scotia.
    Can Med Assoc J; 1985 Aug; 133(4):301. PubMed ID: 4016641
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection provided by hepatitis B vaccine.
    Paul Y
    Indian Pediatr; 2001 Mar; 38(3):301-2. PubMed ID: 11255315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunogenicity and safety of hepatitis B virus vaccine].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Aoyama T
    Kansenshogaku Zasshi; 1985 Oct; 59(10):970-6. PubMed ID: 3936888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.